4.7 Article

c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasion

Journal

MOLECULAR ONCOLOGY
Volume 7, Issue 6, Pages 1116-1128

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molonc.2013.08.007

Keywords

CAFs; c-Ski; P53; SDF-1; Tumor microenvironment

Categories

Funding

  1. National Natural Science Foundation of China [NSFC 81072147, NSFC 30940096]
  2. Natural Science Foundation of Chongqing Science & Technology Commission, China [CSTC2010BB5099]
  3. Ministry of Education, China [20105503110001]
  4. Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education, China [[2011]508]
  5. Major Program of Chongqing Medical University [XBZD201006]
  6. Scientific Research Foundation for the Returned Overseas Scholars of Chongqing Medical University
  7. National Institutes of Health [R01CA151610]
  8. Avon Foundation [02-2010-068]

Ask authors/readers for more resources

Aberrant expression of c-Ski oncoprotein in some tumor cells has been shown to be associated with cancer development. However, the role of c-Ski in cancer-associated fibroblasts (CAFs) of tumor microenvironment has not been characterized. In the current study, we found that c-Ski is highly expressed in CAFs derived from breast carcinoma microenvironment and this CAF-associated c-Ski expression is associated with invasion and metastasis of human breast tumors. We showed that c-Ski overexpression in immortalized breast normal fibroblasts (NFs) induces conversion to breast CAFs by repressing p53 and thereby upregulating SDF-1 in NFs. SDF-1 treatment or p53 knockdown in NFs had similar effects on the activation of NFs as c-Ski overexpression. The c-Ski-activated CAFs show increased proliferation, migration, invasion and contraction compared with NFs. Furthermore, c-Ski-activated CAFs facilitated the migration and invasion of MDA-MB-231 breast cancer cells. Our data suggest that c-Ski is an important regulator in the activation of CAFs and may serve as a potential therapeutic target to block breast cancer progression. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available